It also discusses the current and potential future relevance of MOGAD-specific animal models and translational imaging for defining distinct pathophysiological features in MOGAD compared with important differential diagnoses, especially MS (17) and AQP4-IgG seropositive NMOSD (18). This evidence concerns the gene AQP4 and myeloid sarcoma.